Published in Clin Exp Immunol on March 01, 2011
Different subsets of natural killer T cells may vary in their roles in health and disease. Immunology (2014) 1.01
NKT cells stimulated by long fatty acyl chain sulfatides significantly reduce the incidence of type 1 diabetes in nonobese diabetic mice [corrected]. PLoS One (2012) 0.91
Dendritic cell subsets in type 1 diabetes: friend or foe? Front Immunol (2013) 0.88
CD1d- and MR1-Restricted T Cells in Sepsis. Front Immunol (2015) 0.81
Structure-guided design of an invariant natural killer T cell agonist for optimum protection from type 1 diabetes in non-obese diabetic mice. Clin Exp Immunol (2011) 0.80
Selective Conditions Are Required for the Induction of Invariant NKT Cell Hyporesponsiveness by Antigenic Stimulation. J Immunol (2015) 0.79
T helper type 2-polarized invariant natural killer T cells reduce disease severity in acute intra-abdominal sepsis. Clin Exp Immunol (2014) 0.76
PD-1 and its ligands in tolerance and immunity. Annu Rev Immunol (2008) 19.24
The biology of NKT cells. Annu Rev Immunol (2007) 14.43
CD1: antigen presentation and T cell function. Annu Rev Immunol (2004) 6.89
PD-1 and PD-1 ligands: from discovery to clinical application. Int Immunol (2007) 6.24
CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms. Mol Cell Biol (2005) 6.18
CD8alpha+ and CD8alpha- subclasses of dendritic cells direct the development of distinct T helper cells in vivo. J Exp Med (1999) 6.06
CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL. Immunity (1995) 5.77
Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proc Natl Acad Sci U S A (1999) 5.66
The unconventional lifestyle of NKT cells. Nat Rev Immunol (2002) 4.79
The surface phenotype of dendritic cells purified from mouse thymus and spleen: investigation of the CD8 expression by a subpopulation of dendritic cells. J Exp Med (1992) 4.58
Raising the NKT cell family. Nat Immunol (2010) 3.79
Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes. Nat Med (2001) 3.56
The natural killer T-cell ligand alpha-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nat Med (2001) 3.39
Editing of CD1d-bound lipid antigens by endosomal lipid transfer proteins. Science (2003) 3.05
Glycolipid antigen induces long-term natural killer T cell anergy in mice. J Clin Invest (2005) 2.85
Modulation of CD1d-restricted NKT cell responses by using N-acyl variants of alpha-galactosylceramides. Proc Natl Acad Sci U S A (2005) 2.83
Harnessing invariant NKT cells in vaccination strategies. Nat Rev Immunol (2009) 2.79
PD-1 signaling in primary T cells. Immunol Rev (2009) 2.66
Reversal of in vitro T cell clonal anergy by IL-2 stimulation. Int Immunol (1992) 2.39
The length of lipids bound to human CD1d molecules modulates the affinity of NKT cell TCR and the threshold of NKT cell activation. J Exp Med (2007) 2.37
CD1-restricted NK T cells protect nonobese diabetic mice from developing diabetes. J Exp Med (2001) 2.26
Immune cell crosstalk in type 1 diabetes. Nat Rev Immunol (2010) 2.26
alpha-Galactosylceramide therapy for autoimmune diseases: prospects and obstacles. Nat Rev Immunol (2005) 2.02
CTLA-4 ligation delivers a unique signal to resting human CD4 T cells that inhibits interleukin-2 secretion but allows Bcl-X(L) induction. J Immunol (1998) 2.01
Kinetics and cellular site of glycolipid loading control the outcome of natural killer T cell activation. Immunity (2009) 2.00
The countervailing actions of myeloid and plasmacytoid dendritic cells control autoimmune diabetes in the nonobese diabetic mouse. J Immunol (2007) 1.89
Janus-like role of regulatory iNKT cells in autoimmune disease and tumour immunity. Nat Rev Immunol (2003) 1.81
The NKT cell system: bridging innate and acquired immunity. Nat Immunol (2003) 1.80
Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets. Proc Natl Acad Sci U S A (2001) 1.79
PD-1/PD-L blockade prevents anergy induction and enhances the anti-tumor activities of glycolipid-activated invariant NKT cells. J Immunol (2009) 1.56
Improved outcomes in NOD mice treated with a novel Th2 cytokine-biasing NKT cell activator. J Immunol (2007) 1.36
Cutting edge: Programmed death-1/programmed death ligand 1 interaction regulates the induction and maintenance of invariant NKT cell anergy. J Immunol (2008) 1.32
NKT cell-plasmacytoid dendritic cell cooperation via OX40 controls viral infection in a tissue-specific manner. Immunity (2009) 1.32
Lysosomal recycling terminates CD1d-mediated presentation of short and polyunsaturated variants of the NKT cell lipid antigen alphaGalCer. Proc Natl Acad Sci U S A (2009) 1.31
Cutting edge: impaired glycosphingolipid trafficking and NKT cell development in mice lacking Niemann-Pick type C1 protein. J Immunol (2006) 1.31
Ligation of CD28 receptor by B7 induces formation of D-3 phosphoinositides in T lymphocytes independently of T cell receptor/CD3 activation. Eur J Immunol (1993) 1.30
Saposin B is the dominant saposin that facilitates lipid binding to human CD1d molecules. Proc Natl Acad Sci U S A (2007) 1.29
The Niemann-Pick type C2 protein loads isoglobotrihexosylceramide onto CD1d molecules and contributes to the thymic selection of NKT cells. J Exp Med (2007) 1.29
Activated NKT cells inhibit autoimmune diabetes through tolerogenic recruitment of dendritic cells to pancreatic lymph nodes. J Immunol (2005) 1.26
Evolutionary constraints on CD1 structure: insights from comparative genomic analysis. Trends Immunol (2003) 1.21
Presentation of alpha-galactosylceramide by murine CD1d to natural killer T cells is facilitated by plasma membrane glycolipid rafts. Immunology (2004) 1.12
Protection from type 1 diabetes by invariant NK T cells requires the activity of CD4+CD25+ regulatory T cells. J Immunol (2006) 1.05
Invariant natural killer T cells: innate-like T cells with potent immunomodulatory activities. Tissue Antigens (2009) 1.01
Carbohydrate specificity of the recognition of diverse glycolipids by natural killer T cells. Immunol Rev (2009) 1.00
Both CD28 ligands CD80 (B7-1) and CD86 (B7-2) activate phosphatidylinositol 3-kinase, and wortmannin reveals heterogeneity in the regulation of T cell IL-2 secretion. Int Immunol (1995) 0.96
Synthetic iNKT cell-agonists as vaccine adjuvants--finding the balance. Curr Opin Immunol (2010) 0.96
Lipid rafts are required for efficient signal transduction by CD1d. Biochem Biophys Res Commun (2005) 0.94
Interleukin-4 but not interleukin-10 protects against spontaneous and recurrent type 1 diabetes by activated CD1d-restricted invariant natural killer T-cells. Diabetes (2004) 0.92
Invariant natural killer T-cell control of type 1 diabetes: a dendritic cell genetic decision of a silver bullet or Russian roulette. Diabetes (2009) 0.90
Ligand-dependent induction of noninflammatory dendritic cells by anergic invariant NKT cells minimizes autoimmune inflammation. J Immunol (2008) 0.87
An alpha-galactosylceramide C20:2 N-acyl variant enhances anti-inflammatory and regulatory T cell-independent responses that prevent type 1 diabetes. Clin Exp Immunol (2009) 0.83
Recognition of a lipid antigen by CD1-restricted alpha beta+ T cells. Nature (1994) 6.13
A novel pathogenic taxon of the Mycobacterium tuberculosis complex, Canetti: characterization of an exceptional isolate from Africa. Int J Syst Bacteriol (1997) 5.28
CD1-restricted T cell recognition of microbial lipoglycan antigens. Science (1995) 5.03
An antimicrobial activity of cytolytic T cells mediated by granulysin. Science (1998) 5.02
Role of the major antigen of Mycobacterium tuberculosis in cell wall biogenesis. Science (1997) 4.96
Nuclear-encoded proteins target to the plastid in Toxoplasma gondii and Plasmodium falciparum. Proc Natl Acad Sci U S A (1998) 4.28
Murine CD1d-restricted T cell recognition of cellular lipids. Immunity (2000) 3.57
Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes. Nat Med (2001) 3.56
Differential effects of cytolytic T cell subsets on intracellular infection. Science (1997) 3.39
Evidence for extrathymic changes in the T cell receptor gamma/delta repertoire. J Exp Med (1990) 3.38
Structural requirements for glycolipid antigen recognition by CD1b-restricted T cells. Science (1997) 3.23
CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells. J Exp Med (1998) 2.94
CD1c-mediated T-cell recognition of isoprenoid glycolipids in Mycobacterium tuberculosis infection. Nature (2000) 2.87
The embAB genes of Mycobacterium avium encode an arabinosyl transferase involved in cell wall arabinan biosynthesis that is the target for the antimycobacterial drug ethambutol. Proc Natl Acad Sci U S A (1996) 2.83
The complete genome sequence and analysis of Corynebacterium diphtheriae NCTC13129. Nucleic Acids Res (2003) 2.82
Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice. J Exp Med (1993) 2.47
Activation of the pro-drug ethionamide is regulated in mycobacteria. J Biol Chem (2000) 2.43
Self-recognition of CD1 by gamma/delta T cells: implications for innate immunity. J Exp Med (2000) 2.30
Identification of a gene involved in the biosynthesis of cyclopropanated mycolic acids in Mycobacterium tuberculosis. Proc Natl Acad Sci U S A (1995) 2.25
Crystal structure of the secreted form of antigen 85C reveals potential targets for mycobacterial drugs and vaccines. Nat Struct Biol (2000) 2.24
Biogenesis of the mycobacterial cell wall and the site of action of ethambutol. Antimicrob Agents Chemother (1995) 2.17
Genetic and functional analysis of the Ia antigens: their possible role in regulating the immune response. Transplant Rev (1976) 2.15
CD1c restricts responses of mycobacteria-specific T cells. Evidence for antigen presentation by a second member of the human CD1 family. J Immunol (1996) 2.13
The mannose receptor delivers lipoglycan antigens to endosomes for presentation to T cells by CD1b molecules. Immunity (1997) 2.07
CD1-restricted microbial lipid antigen-specific recognition found in the CD8+ alpha beta T cell pool. J Immunol (1999) 1.96
Complete nucleotide sequence of a gene encoding a functional human class I histocompatibility antigen (HLA-CW3). EMBO J (1984) 1.92
Thiolactomycin and related analogues as novel anti-mycobacterial agents targeting KasA and KasB condensing enzymes in Mycobacterium tuberculosis. J Biol Chem (2000) 1.92
Response of murine and normal human skin to injection of allogeneic blood-derived psoriatic immunocytes: detection of T cells expressing receptors typically present on natural killer cells, including CD94, CD158, and CD161. Arch Dermatol (1999) 1.89
Biosynthesis of the linkage region of the mycobacterial cell wall. J Biol Chem (1996) 1.76
Identification and substrate specificity of beta -ketoacyl (acyl carrier protein) synthase III (mtFabH) from Mycobacterium tuberculosis. J Biol Chem (2000) 1.69
CD1b-mediated T cell recognition of a glycolipid antigen generated from mycobacterial lipid and host carbohydrate during infection. J Exp Med (2000) 1.67
Cytoplasmic tail-dependent localization of CD1b antigen-presenting molecules to MIICs. Science (1996) 1.66
Molecular recognition of lipid antigens by T cell receptors. J Exp Med (1999) 1.65
Mycolic acid structure determines the fluidity of the mycobacterial cell wall. J Biol Chem (1996) 1.63
CD1-restricted T cells in host defense to infectious diseases. Curr Top Microbiol Immunol (2007) 1.62
Molecular interaction of CD1b with lipoglycan antigens. Immunity (1998) 1.60
The tyrosine-containing cytoplasmic tail of CD1b is essential for its efficient presentation of bacterial lipid antigens. Immunity (1998) 1.59
Antimycobacterial action of thiolactomycin: an inhibitor of fatty acid and mycolic acid synthesis. Antimicrob Agents Chemother (1996) 1.57
A pathway of costimulation that prevents anergy in CD28- T cells: B7-independent costimulation of CD1-restricted T cells. J Exp Med (1995) 1.54
Adult botulism. Muscle Nerve (1997) 1.53
Resting functional connectivity between the hemispheres in childhood absence epilepsy. Neurology (2011) 1.51
Antigen-induced Ca2+ signaling and desensitization in B cells. J Immunol (1990) 1.50
Cellular origins of co-stimulator (IL2) and its activity in cytotoxic T lymphocyte responses. J Immunol (1980) 1.48
IL-4 prevents insulitis and insulin-dependent diabetes mellitus in nonobese diabetic mice by potentiation of regulatory T helper-2 cell function. J Immunol (1997) 1.48
Defective thymic T cell activation by concanavalin A and anti-CD3 in autoimmune nonobese diabetic mice. Evidence for thymic T cell anergy that correlates with the onset of insulitis. J Immunol (1991) 1.45
Low expression level but potent antigen presenting function of CD1d on monocyte lineage cells. Eur J Immunol (2000) 1.43
The CD1 family of lipid antigen-presenting molecules. Immunol Today (1998) 1.42
Evasion and subversion of antigen presentation by Mycobacterium tuberculosis. Tissue Antigens (2009) 1.41
Mycobacterium tuberculosis lipomannan induces apoptosis and interleukin-12 production in macrophages. Infect Immun (2004) 1.40
Inhibitor of protein synthesis blocks long-term behavioral sensitization in the isolated gill-withdrawal reflex of Aplysia. J Neurobiol (1989) 1.38
Analysis of human V alpha 24+ CD4+ NKT cells activated by alpha-glycosylceramide-pulsed monocyte-derived dendritic cells. J Immunol (2000) 1.38
Biosynthetic origin of mycobacterial cell wall galactofuranosyl residues. Tuber Lung Dis (1997) 1.38
Overexpression of CD1d by keratinocytes in psoriasis and CD1d-dependent IFN-gamma production by NK-T cells. J Immunol (2000) 1.37
Galactan biosynthesis in Mycobacterium tuberculosis. Identification of a bifunctional UDP-galactofuranosyltransferase. J Biol Chem (2001) 1.36
Distinct antibody specificities to a 64-kD islet cell antigen in type 1 diabetes as revealed by trypsin treatment. J Exp Med (1990) 1.36
Conservation of a CD1 multigene family in the guinea pig. J Immunol (1999) 1.34
The pimB gene of Mycobacterium tuberculosis encodes a mannosyltransferase involved in lipoarabinomannan biosynthesis. J Biol Chem (1999) 1.33
CD1 expression in human atherosclerosis. A potential mechanism for T cell activation by foam cells. Am J Pathol (1999) 1.33
CD1 expression by dendritic cells in human leprosy lesions: correlation with effective host immunity. J Immunol (1999) 1.32
Antimycobacterial activities of isoxyl and new derivatives through the inhibition of mycolic acid synthesis. Antimicrob Agents Chemother (1999) 1.30
Distinct cytokine profiles of neonatal natural killer T cells after expansion with subsets of dendritic cells. J Exp Med (2001) 1.30
The mannose cap of mycobacterial lipoarabinomannan does not dominate the Mycobacterium-host interaction. Cell Microbiol (2007) 1.29
Mycobacterium tuberculosis cell envelope. Curr Top Microbiol Immunol (1996) 1.29
The M. tuberculosis antigen 85 complex and mycolyltransferase activity. Lett Appl Microbiol (2002) 1.28
Biosynthesis of the galactan component of the mycobacterial cell wall. J Biol Chem (2000) 1.28
Biochemical characterization of acyl carrier protein (AcpM) and malonyl-CoA:AcpM transacylase (mtFabD), two major components of Mycobacterium tuberculosis fatty acid synthase II. J Biol Chem (2001) 1.26
In vitro analysis of allogeneic lymphocyte interaction. I. Characterization and cellular origin of an Ia-positive helper factor-allogeneic effect factor. J Exp Med (1977) 1.26
p38 mitogen-activated protein kinase mediates signal integration of TCR/CD28 costimulation in primary murine T cells. J Immunol (1999) 1.25
Evidence that a peptide spanning the B-C junction of proinsulin is an early Autoantigen epitope in the pathogenesis of type 1 diabetes. J Immunol (2001) 1.23
Structure, function and biosynthesis of the Mycobacterium tuberculosis cell wall: arabinogalactan and lipoarabinomannan assembly with a view to discovering new drug targets. Biochem Soc Trans (2007) 1.22
Polyprenyl phosphate biosynthesis in Mycobacterium tuberculosis and Mycobacterium smegmatis. J Bacteriol (2000) 1.20
TCR and CD28 are coupled via ZAP-70 to the activation of the Vav/Rac-1-/PAK-1/p38 MAPK signaling pathway. J Immunol (1999) 1.18
Diverse CD1d-restricted reactivity patterns of human T cells bearing "invariant" AV24BV11 TCR. Eur J Immunol (1998) 1.17
Estimation of light-chain gene reiteration of mouse immunoglobulin by DNA-RNA hybridization. Proc Natl Acad Sci U S A (1973) 1.16
Differential expression of CC chemokines and the CCR5 receptor in the pancreas is associated with progression to type I diabetes. J Immunol (2000) 1.16
Truncated structural variants of lipoarabinomannan in ethambutol drug-resistant strains of Mycobacterium smegmatis. Inhibition of arabinan biosynthesis by ethambutol. J Biol Chem (1996) 1.16
Thymic T cell anergy in autoimmune nonobese diabetic mice is mediated by deficient T cell receptor regulation of the pathway of p21ras activation. J Exp Med (1993) 1.15
Characterization of a T cell line bearing natural killer receptors and capable of creating psoriasis in a SCID mouse model system. J Dermatol Sci (2000) 1.15
DTI abnormalities in anterior corpus callosum of rats with spike-wave epilepsy. Neuroimage (2009) 1.13
Evidence for human CD4+ T cells in the CD1-restricted repertoire: derivation of mycobacteria-reactive T cells from leprosy lesions. J Immunol (2000) 1.12
Selective diapedesis of Th1 cells induced by endothelial cell RANTES. J Immunol (1999) 1.11
Clinical use of ictal SPECT in secondarily generalized tonic-clonic seizures. Brain (2009) 1.11
Structure and function of the CD1 family of MHC-like cell surface proteins. Immunol Rev (1995) 1.11
Altered thymic and peripheral T-lymphocyte repertoire preceding onset of diabetes in NOD mice. Diabetes (1991) 1.09
Human double-negative T cells in systemic lupus erythematosus provide help for IgG and are restricted by CD1c. J Immunol (2000) 1.09
Stimulation of mycolic acid biosynthesis by incorporation of cis-tetracos-5-enoic acid in a cell-wall preparation from Mycobacterium smegmatis. Biochim Biophys Acta (1993) 1.09
Human CD1b and CD1c isoforms survey different intracellular compartments for the presentation of microbial lipid antigens. J Exp Med (2000) 1.09
Intracellular trafficking pathway of newly synthesized CD1b molecules. EMBO J (2002) 1.08
Potent expansion of human natural killer T cells using alpha-galactosylceramide (KRN7000)-loaded monocyte-derived dendritic cells, cultured in the presence of IL-7 and IL-15. J Immunol Methods (2001) 1.06
Isolation of polysomes from mouse plasmacytomas. Nature (1969) 1.05
Class I histocompatibility antigens and insulin receptors: evidence for interactions. Proc Natl Acad Sci U S A (1986) 1.05
Photoaffinity labeling demonstrates binding between Ia molecules and nominal antigen on antigen-presenting cells. Proc Natl Acad Sci U S A (1986) 1.04
Persistence of serum antibodies to 64,000-Mr islet cell protein after onset of type I diabetes. Diabetes (1990) 1.03
Regulation of fas ligand expression during activation-induced cell death in T cells by p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinase. J Exp Med (2000) 1.03